Johan Vansteenkiste

6PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 16, 2022
A prospective, multicenter, noninterventional study of decision factors in the first-line treatment of metastatic non-small cell lung cancer.

Anne Sibille, Frederique Bustin, Luciano Carestia

|Feb 02, 2022
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.

David R Spigel, Corinne Faivre-Finn, Jhanelle E Gray

|Jan 15, 2020
Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS data.

Benoît Colinet, Jan P Van Meerbeeck, Tine Cuppens

|Nov 17, 2019
A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non-Small Cell Lung Cancer.

Benjamin Dizier, Andrea Callegaro, Muriel Debois

|Aug 02, 2019
Capmatinib for the treatment of non-small cell lung cancer.

Johan Filip Vansteenkiste, Charlotte Van De Kerkhove, Els Wauters

|Jul 11, 2018
Phenotype molding of stromal cells in the lung tumor microenvironment.

Diether Lambrechts, Els Wauters, Bram Boeckx

Pageof 1

Frequent Collaborators

1 joint publications

Lecia V Sequist

1 joint publications

David R Spigel

1 joint publications

Corinne Faivre-Finn

1 joint publications

David Planchard